$CFRX - ContraFect Data Presentations at the 33rd Annual ECCMID Meeting Highlight the Potential Efficacy of Lysin CF-370 Against Antibiotic Resistant Gram-negative Pathogens: https://finance.yahoo.com/news/contrafect-data-presentations-33rd-annual-123000430.html
$CNSP - Over 100 Patients Now Enrolled in CNS Pharmaceuticals’ (NASDAQ: CNSP) Potentially Pivotal Study Evaluating Berubicin for the Treatment of Glioblastoma Multiforme (GBM): https://finance.yahoo.com/news/over-100-patients-now-enrolled-124500557.html